LONP1 and CLPXP improve PD-related phenotypes, respectively, by degrading PINK1 and parkinson disease protein 7, which are involved in the pathological process of PD, and reducing the accumulation of α-synuclein variant A53T [151]. Here, PINK1 is linked to Parkinson disease.